Tenax Therapeutics/ US88032L1008 /

6/29/2022 9:52:27 PM	Chg. -0.07	Volume	Bid-	Ask-	High	Low
0.30USD	-18.97%	261 Turnover: 79.90	-Bid Size: -	-Ask Size: -	0.31	0.29

GlobeNewswire 1/31 Tenax Therapeutics Appoints Robyn Hunter to the Board of Directors

GlobeNewswire 1/4 Tenax Therapeutics Provides Update on TNX-102, TNX-103 and TNX-201 Clinical Programs

GlobeNewswire 12/6/2021 Avalo Appoints Two New Independent Directors to Its Board

GlobeNewswire 4/5/2018 Artificial Blood and Plasma 2018 - Global Markets to 2027

GlobeNewswire 4/26/2017 Orion Group Interim Report January-March 2017

GlobeNewswire 2/8/2017 Orion Group Financial Statement Release for 2016

GlobeNewswire 10/25/2016 Orion Group Interim Report January-September 2016

GlobeNewswire 7/19/2016 Orion Group Half-Yearly Report January-June 2016

GlobeNewswire 4/27/2016 Orion Group Interim Report January-March 2016

GlobeNewswire 2/2/2016 Orion Group Financial Statement Release for 2015

GlobeNewswire 10/27/2015 Orion Group Interim Report January-September 2015

GlobeNewswire 7/28/2015 Orion Group Interim Report January-June 2015

GlobeNewswire 4/29/2015 Orion Group Interim Report January-March 2015

GlobeNewswire 2/4/2015 Orion Group Financial Statement Release for 2014

GlobeNewswire 10/21/2014 Orion Group Interim Report January-September 2014